We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $83.5M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$222M
AUM Growth
+$23.3M
Cap. Flow
+$3.97M
Cap. Flow %
1.79%
Top 10 Hldgs %
47.48%
Holding
42
New
17
Increased
3
Reduced
9
Closed
11

Top Sells

Rank Stock Value
1
AZO icon
AutoZone
AZO
+$11.5M
2
DE icon
Deere & Co
DE
+$10.3M
3
APH icon
Amphenol
APH
+$9.86M
4
MS icon
Morgan Stanley
MS
+$9.69M
5
GS icon
Goldman Sachs
GS
+$9.66M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Healthcare 18.27%
3 Industrials 17.16%
4 Financials 8.29%
5 Consumer Discretionary 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
1
Applied Materials
AMAT
$347B
$11.5M 5.19%
79,609
-931
-1% -$117K
COR icon
2
Cencora
COR
$62B
$11.3M 5.1%
58,829
-1,220
-2% -$211K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.12T
$11M 4.97%
+92,052
New +$10.6M
BOTZ icon
4
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.14B
$10.6M 4.79%
+369,584
New +$9.8M
ODFL icon
5
Old Dominion Freight Line
ODFL
$46.3B
$10.3M 4.63%
48,598
+3,062
+7% +$496K
HCA icon
6
HCA Healthcare
HCA
$88.4B
$10.1M 4.57%
33,413
-515
-2% -$143K
WMT icon
7
Walmart Inc
WMT
$909B
$10M 4.51%
191,091
-1,665
-0.9% -$84K
NVO
8
Novo Nordisk
NVO
$228B
$9.8M 4.42%
121,094
+95,250
+369% +$7.78M
AAPL icon
9
Apple
AAPL
$4.97T
$9.76M 4.4%
50,338
-1,230
-2% -$214K
MSFT icon
10
Microsoft
MSFT
$2.9T
$9.51M 4.29%
+27,930
New +$8.75M
AMP icon
11
Ameriprise Financial
AMP
$47.8B
$9.49M 4.28%
28,575
-4,034
-12% -$1.24M
ETN icon
12
Eaton
ETN
$141B
$9.42M 4.25%
+46,850
New +$8.24M
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$123B
$9.28M 4.18%
26,375
-16,252
-38% -$5.48M
PH icon
14
Parker-Hannifin
PH
$120B
$9.19M 4.14%
23,570
AME icon
15
Ametek
AME
$53.9B
$9.18M 4.14%
56,720
FISV
16
Fiserv Inc
FISV
$29.7B
$8.94M 4.03%
+70,850
New +$8.34M
V icon
17
Visa
V
$677B
$8.91M 4.02%
+37,515
New +$8.59M
MCD icon
18
McDonald's
MCD
$193B
$8.79M 3.96%
+29,450
New +$8.56M
TSLA icon
19
Tesla
TSLA
$1.18T
$7.99M 3.6%
+30,540
New +$6.11M
EWL icon
20
iShares MSCI Switzerland ETF
EWL
$2.17B
$2.37M 1.07%
+51,195
New +$2.41M
EWW icon
21
iShares MSCI Mexico ETF
EWW
$1.89B
$2.34M 1.05%
37,640
+10,490
+39% +$641K
EWJ icon
22
iShares MSCI Japan ETF
EWJ
$21.2B
$2.34M 1.05%
+37,789
New +$2.28M
VGT icon
23
Vanguard Information Technology ETF
VGT
$133B
$2.06M 0.93%
+37,216
New +$1.87M
VNM icon
24
VanEck Vietnam ETF
VNM
$478M
$1.58M 0.71%
+119,088
New +$1.49M
FEZ icon
25
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.29B
$1.58M 0.71%
+34,278
New +$1.56M

Similar funds

Marvin & Palmer Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Marvin & Palmer Associates held 42 positions worth $222M, up 12% from $199M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Marvin & Palmer Associates's Q2 2023 filing shows 17 new, 3 increased, 9 reduced and 11 closed positions. Its largest new stake was Alphabet (Google) Class A: 92,052 shares worth $11M. The largest sale was AutoZone, an estimated $11.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Marvin & Palmer Associates's largest Q2 2023 buy was Alphabet (Google) Class A: 92,052 shares worth $11M.
  • Marvin & Palmer Associates added most to Novo Nordisk in Q2 2023, an estimated $7.78M increase.
  • Marvin & Palmer Associates's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $5.48M.
  • Marvin & Palmer Associates fully exited AutoZone in Q2 2023, selling an estimated $11.5M.
  • Marvin & Palmer Associates's ten largest holdings make up 47% of its $222M portfolio in Q2 2023.
  • Marvin & Palmer Associates opened 17 new positions and closed 11 in Q2 2023.
  • Marvin & Palmer Associates's portfolio value rose 12% quarter-over-quarter to $222M.

Based on Marvin & Palmer Associates's 13F filing for Q2 2023, filed 11 Aug 2023.